AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.314 19 days ( -3.37 % )
Last Price $0.460 -3.16 %
High/ Low $0.455 - $0.475 9.89%
Chg 7 Days 5.75 % $0.435 $0.460
Chg 30 Days 19.48 % $0.385 $0.460
Chg 12 mos 29.58 % $0.355 $0.460
Trend - 3 mos 27.76 % Width: 28.67 %
Trend - 12 mos 37.34 % Width: 36.56 %
Pred. range - 3 mos $0.503 - $0.648 9.45 % - 40.82 %
Pred. range - 12 mos $0.494 - $0.675 7.42 % - 46.70 %
Short MA avg 3 mos Buy May 16, 2024 - 6 days
Long MA avg 3 mos Buy Apr 22, 2024 - 23 days
Short/Long MA avg 3 mos Buy Apr 26, 2024 - 20 days
Short MA avg 12 mos Buy Apr 22, 2024 - 23 days
Long MA avg 12 mos Buy Apr 18, 2024 - 25 days
Short/Long MA avg 12 mos Buy Dec 04, 2023 - 117 days
Pivot Short Sell Apr 17, 2024 - 26 days
Bollinger Buy Apr 24, 2024 - 21 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Immutep Limited

Immutep Limited Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, wh... IMM.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT